France· FR:63344192
SURMONTIL 25 mg, comprimé
A medicinal product containing trimipramine (maléate acide de), registered in France by NEURAXPHARM FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TRIMIPRAMINE (MALÉATE ACIDE DE)
- Manufacturer
- NEURAXPHARM FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400931022961plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 50 comprimé(s)EUR 6.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trimipramine (maléate acide de) in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSurmontil 25mg tabletsSanofi
- SwitzerlandSurmontil 25 mg, TablettenNeuraxpharm Switzerland AG
- NorwayStangylSanofi-aventis
- CanadaTRIMIPRAMINEAA PHARMA INC
- GermanyStangylNeuraxpharm Arzneimittel Gmbh
- United StatesTrimipramineBreckenridge Pharmaceutical, Inc.
- FinlandSurmontilsanofi-aventis Oy
- IrelandSurmontil 25mg film-coated TabletsNeuraxpharm Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Stangyl, Stangyl Tabs
- Spain · Surmontil
- United Kingdom (Northern Ireland) · Trimipramine Focus Pharmaceuticals, Trimipramine Glenmark Pharmaceuticals Europe
- Ireland · Surmontil
- Italy · Surmontil
- Norway · Surmontil
- Portugal · Surmontil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb32f47d-970c-4ee3-b845-9c5919b80c9b GET /v1/drugs/cb32f47d-970c-4ee3-b845-9c5919b80c9b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63344192",
"date_amm": "1989-10-19",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TRIMIPRAMINE (MALÉATE ACIDE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about trimipramine (maléate acide de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.